240 related articles for article (PubMed ID: 35708337)
1. A High-Carbohydrate Diet Prolongs Dysbiosis and Clostridioides difficile Carriage and Increases Delayed Mortality in a Hamster Model of Infection.
Bhute SS; Mefferd CC; Phan JR; Ahmed M; Fox-King AE; Alarcia S; Villarama JV; Abel-Santos E; Hedlund BP
Microbiol Spectr; 2022 Aug; 10(4):e0180421. PubMed ID: 35708337
[TBL] [Abstract][Full Text] [Related]
2. CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models.
Hu X; Dong R; Huang S; Zeng Y; Zhan W; Gao X; Tian D; Peng J; Xu J; Wang T; Zhang Y; Wang X; Zhang X; Liu J; Guang B; Yang T
Antimicrob Agents Chemother; 2023 May; 67(5):e0170422. PubMed ID: 37052498
[TBL] [Abstract][Full Text] [Related]
3. A High-Fat/High-Protein, Atkins-Type Diet Exacerbates
Mefferd CC; Bhute SS; Phan JR; Villarama JV; Do DM; Alarcia S; Abel-Santos E; Hedlund BP
mSystems; 2020 Feb; 5(1):. PubMed ID: 32047064
[No Abstract] [Full Text] [Related]
4. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
[TBL] [Abstract][Full Text] [Related]
5. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
6. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model.
Hryckowian AJ; Van Treuren W; Smits SA; Davis NM; Gardner JO; Bouley DM; Sonnenburg JL
Nat Microbiol; 2018 Jun; 3(6):662-669. PubMed ID: 29686297
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
[TBL] [Abstract][Full Text] [Related]
9. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
Collins DA; Riley TV
Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
[TBL] [Abstract][Full Text] [Related]
10. An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.
Phan JR; Do DM; Truong MC; Ngo C; Phan JH; Sharma SK; Schilke A; Mefferd CC; Villarama JV; Lai D; Consul A; Hedlund BP; Firestine SM; Abel-Santos E
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0143521. PubMed ID: 34780262
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
12. Correlating Antibiotic-Induced Dysbiosis to
Moore JH; Salahi A; Honrado C; Warburton C; Tate S; Warren CA; Swami NS
ACS Infect Dis; 2023 Oct; 9(10):1878-1888. PubMed ID: 37756389
[TBL] [Abstract][Full Text] [Related]
13. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
Lesniak NA; Schubert AM; Sinani H; Schloss PD
mSphere; 2021 May; 6(3):. PubMed ID: 33952668
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
15. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
[TBL] [Abstract][Full Text] [Related]
16. Investigating the impact of antibiotic-induced dysbiosis on protection from
Uddin MJ; Thompson B; Leslie JL; Fishman C; Sol-Church K; Kumar P; Petri WA
mBio; 2024 Mar; 15(3):e0333823. PubMed ID: 38376154
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection.
Abutaleb NS; Seleem MN
Sci Rep; 2021 Mar; 11(1):7093. PubMed ID: 33782498
[TBL] [Abstract][Full Text] [Related]
19. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
[TBL] [Abstract][Full Text] [Related]
20. Gut metabolites predict Clostridioides difficile recurrence.
Dawkins JJ; Allegretti JR; Gibson TE; McClure E; Delaney M; Bry L; Gerber GK
Microbiome; 2022 Jun; 10(1):87. PubMed ID: 35681218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
